Healthcare technology company SoundHealth has secured $12.25 million in Series A funding, marking an important step in its mission to improve breathing and sleep health through artificial intelligence and sound-based medical technology. The fresh investment will help the company expand manufacturing, grow its commercial operations, and continue developing its wearable healthcare devices. As demand increases for non-drug treatment options, SoundHealth aims to make its AI-powered solutions available to more patients and healthcare providers.
Shangbay Capital Leads the Investment
The Series A funding round was led by Shangbay Capital, a healthcare-focused investment firm. According to SoundHealth, the new capital will support the company’s next stage of growth by increasing production, expanding its market presence, and advancing research and product development.
Dr. Paramesh Gopi, CEO of SoundHealth, said the company is excited to partner with Shangbay Capital as it works to bring its technology to more people. He added that the firm’s experience in growing healthcare companies will support SoundHealth’s long-term vision. Dr. Bryant Lin, Co-founder of SoundHealth, also welcomed the partnership and said the company looks forward to working closely with Shangbay Capital as it continues to develop innovative healthcare solutions.
AI-Powered Wearable Offers Drug-Free Relief
SoundHealth is known for SONU, an FDA-cleared wearable medical device designed to provide drug-free relief from nasal congestion. The device combines artificial intelligence, computer vision, and acoustic resonance technology to deliver personalized therapy. Users first complete a facial scan using a smartphone. The company’s AI technology analyzes the scan to create a personalized treatment based on each user’s facial anatomy. SONU then delivers customized acoustic resonance therapy intended to help relieve nasal congestion without medication.
The device is cleared for people 12 years of age and older and is designed for individuals experiencing both allergic and non-allergic rhinitis. According to the company, SONU has already delivered more than 500,000 treatment sessions, reflecting growing interest in personalized, non-invasive healthcare technology.
Expanding Into Sleep Health
Along with its breathing technology, SoundHealth is also developing Spatial Sleep, a wearable device focused on improving sleep health. According to the company, the product uses the same AI-driven facial mapping technology to create personalized sound therapy designed to support better sleep quality.
The company believes this technology can provide another non-drug option for people looking to improve their sleep through personalized treatment.
Growing Support From Healthcare Professionals
SoundHealth said its technology has been recommended by more than 1,000 healthcare professionals, including medical and dental practitioners across the United States. The company continues to work with clinicians as it expands the use of its AI-powered healthcare platform.
The latest funding will also help strengthen partnerships with healthcare providers while supporting broader commercial adoption of its wearable devices.
Looking Ahead
The new Series A investment comes at a time when interest in AI-powered medical devices continues to grow. Patients and healthcare providers are increasingly exploring personalized treatments that reduce reliance on medication while improving everyday health conditions.
With support from Shangbay Capital, SoundHealth plans to expand access to its FDA-cleared SONU device, continue developing new products such as Spatial Sleep, and accelerate innovation in AI-driven healthcare. As the company moves into its next phase of growth, it aims to bring personalized, non-invasive treatment options to a larger number of patients seeking better breathing and sleep health.
